Gilead Global Public Health Awards 2026: Funding for Early Career Researchers
The Gilead Global Public Health Awards 2026 are offering a significant opportunity for early career researchers and public health professionals. This program aims to provide up to $100,000 in research funding over two years. The focus is on supporting investigators from low- and middle-income countries who are dedicated to advancing research priorities related to HIV and viral hepatitis. This initiative is designed to build research capacity globally by supporting emerging talent working on critical public health issues.
About the Gilead Global Public Health Awards
The Global Public Health Awards are specifically designed to support independent early career investigators. These researchers must be based in eligible low- and middle-income countries. The program’s main goal is to encourage research that is driven by local needs and is relevant to the communities it serves. It aims to improve health outcomes for people who are living with or at risk of viral hepatitis (B, C, and D) and HIV. The awards recognize the importance of developing local research leaders who understand the specific healthcare challenges, policy landscapes, and public health priorities within their own regions.
Grant Details and Award Structure
For the 2026 cycle, the Gilead Global Public Health Awards will grant funding to four selected research projects. Each award will provide up to $100,000 to support a research project spanning a two-year period. This financial support is intended to help early career researchers establish themselves as independent investigators. The funding also aims to enable them to generate valuable evidence that can lead to future research initiatives, publications, conference presentations, and inform policy development.
Application Deadline and Timeline
The application period for the Gilead Global Public Health Awards 2026 is currently open. The deadline for submitting applications is August 28, 2026, at 11:59 PM CEST. It is highly recommended that applicants begin preparing their proposals well in advance of this date. Gathering necessary supporting documents, securing mentorship arrangements, obtaining institutional approvals, and detailing budget information can all require substantial preparation time.
Eligibility Criteria for Applicants
The Gilead Global Public Health Awards are targeted towards specific groups of individuals. Eligible applicants include junior faculty members, early career public health researchers, postdoctoral researchers, and emerging independent investigators. These individuals must be working within recognized institutions such as academic research institutions, hospitals, ministries of health, or other public health organizations. The program seeks individuals committed to building long-term careers in public health research and who show a strong dedication to improving the lives of those affected by HIV and viral hepatitis.
Academic and Career Stage Requirements
To be considered for the awards, applicants must hold a relevant terminal degree, such as an MD, MBChB, MBBS, PhD, or an equivalent qualification, at the time of application. A key requirement is that applicants must be within 10 years of completing their terminal degree. However, the program allows for exceptions to this 10-year rule. These exceptions can be made for documented career interruptions, such as parental leave, family bereavement, or other approved reasons.
Employment and Mentorship
Applicants must currently be employed by an academic research institution, hospital, ministry of health, or a recognized public health organization. They should also be on a clear path toward a scientific research appointment, faculty position, or a similar research leadership role. A critical component of the application is the requirement for an in-country research mentor. This mentor must possess extensive experience in fields directly related to HIV, viral hepatitis, or implementation science. Relevant disciplines include public health, economics, engineering, anthropology, psychology, behavioral sciences, and health systems research.
Research Commitment and Focus
A significant aspect of the award is the expectation that recipients will dedicate approximately 50% of their professional time to research activities throughout the two-year award period. This means balancing research responsibilities with any existing administrative, clinical, or teaching duties. Applicants must demonstrate a strong interest in public health research specifically focused on HIV and/or viral hepatitis. The proposed research must be achievable within the two-year timeframe and show the potential to generate impactful evidence through publications, conference presentations, and abstracts.
Eligible Geographic Regions
The Gilead Global Public Health Awards are open to applicants residing in specific regions. These include countries within Africa, the Commonwealth of Independent States, South Asia, and Southeast Asia. Applicants must either be citizens or permanent residents of the country where the research will be conducted. Alternatively, they may hold a valid temporary study visa or a non-immigrant visa that permits them to conduct research for the entire two-year award period. Applicants on temporary visas must also ensure they can obtain visa renewals or extensions if needed.
Supported Research Areas
The program supports a broad range of research topics related to HIV prevention and care, as well as viral hepatitis B, C, and D. It places a strong emphasis on public health implementation science, sustainable development goals within healthcare, community health systems, and prevention strategies. Research focused on improving access to healthcare services and advancing health equity initiatives is also encouraged. The core principle is to fund practical, country-driven solutions that can lead to tangible improvements in public health outcomes and strengthen healthcare delivery systems.
Research Activities That Are Not Eligible
Certain types of research projects are not eligible for funding under the Gilead Global Public Health Awards. These include projects that focus directly on Gilead products, such as comparative studies of pharmaceutical products, product-specific safety, or efficacy studies. Cost-effectiveness studies for specific drugs are also excluded. However, discussions of generic HIV prevention or treatment products within broader public health research contexts are permissible.
The program also does not fund interventional clinical trials, pharmaceutical drug administration studies, or clinical studies examining the safety or efficacy of competitor drugs. Applications must be submitted by a single lead investigator; co-principal investigator applications are not accepted. Furthermore, projects that overlap with existing grants, pending funding sources, or institutional/governmental funding for the same activities are ineligible. Applicants must clearly demonstrate that there is no duplication of financial support for the proposed research.
Significance of the Opportunity
The Global Public Health Awards represent a crucial investment in building research leadership within low- and middle-income countries. This initiative provides emerging researchers with the resources and support needed to build independent research careers. It helps them generate locally relevant public health evidence, strengthen their implementation science skills, and contribute to sustainable healthcare improvements. The awards also expand opportunities for publications and conference presentations, which can enhance future grant competitiveness. For many early career investigators, this funding serves as a vital stepping stone toward becoming recognized public health researchers on national and international stages.
Frequently Asked Questions
What is the main goal of the Gilead Global Public Health Awards?
The main goal is to support early career researchers in low- and middle-income countries to build research capacity and advance studies on HIV and viral hepatitis.
How much funding is available through the awards?
Each of the four selected research projects will receive up to $100,000 to support their work over a two-year period.
Who is eligible to apply for these awards?
Eligible applicants include junior faculty, early career researchers, postdocs, and independent investigators within 10 years of their terminal degree, working in recognized institutions in specific regions.
What types of research are not eligible for funding?
Projects directly focused on Gilead products, interventional clinical trials, or those duplicating existing funding are not eligible.
